Your browser doesn't support javascript.
loading
Normocalcaemic hyperparathyroidism and primary hyperparathyroidism: least significant change for adjusted serum calcium.
Schini, Marian; Jacques, Richard; Oakes, Eleanor; Peel, Nicola; Walsh, Jennifer S; Eastell, Richard.
  • Schini M; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
  • Jacques R; School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
  • Oakes E; Sheffield Teaching Hospitals National Health Service Foundation Trust (STH NHS FT), Sheffield, UK.
  • Peel N; Sheffield Teaching Hospitals National Health Service Foundation Trust (STH NHS FT), Sheffield, UK.
  • Walsh JS; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
  • Eastell R; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Eur J Endocrinol ; 184(1): K7-K10, 2021 Jan.
Article en En | MEDLINE | ID: mdl-33112283
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calcio / Hiperparatiroidismo Primario / Hiperparatiroidismo Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calcio / Hiperparatiroidismo Primario / Hiperparatiroidismo Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article